-
Zacks Research Weighs in on Esperion Therapeutics, Inc.'s Q1 2025 Earnings (NASDAQ:ESPR)
来源: Buzz FX / 04 10月 2024 07:01:10 America/New_York
Zacks Research Weighs in on Esperion Therapeutics, Inc.'s Q1 2025 Earnings (NASDAQ:ESPR) Written by MarketBeat October 4, 2024 Share Link copied to clipboard. Esperion Therapeutics, Inc. ( NASDAQ:ESPR - Free Report ) - Zacks Research droppe
Read more...